-
www.ahrq.gov/prevention/resources/vision/visfig2.html
October 01, 2002 - The "stage" column in the framework shows that physiological changes resulting from an underlying disease
-
effectivehealthcare.ahrq.gov/products/women-hiv/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
October 25, 2010 - Microarray Analysis for
Human Genetic Disease; 2008.
16. Reding KW, Weiss NS, Chen C, et al. … Tamoxifen in the Prevention
of Breast Cancer in Hodgkin's Disease
Survivors; 2010.
50. … Macronutrients,
Mitochondria and Blood
Metabolome/Proteome Disease Risk
Profiles. 2007.
139. … , female/ci, ep, et 30430
8 exp genital diseases, female/ 130131
9 6 and 8 630
10 3 and 7 645 … , female/ci, ep, et 30430
8 exp genital diseases, female/ 130131
9 6 and 8 630
10 3 and 7 645
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
September 01, 2010 - intervention that carries essentially no harm and
great preventive/therapeutic benefits for many diseases … Microarray Analysis for
Human Genetic Disease; 2008.
16. Reding KW, Weiss NS, Chen C, et al. … Tamoxifen in the Prevention
of Breast Cancer in Hodgkin's Disease
Survivors; 2010.
50. … , female/ci, ep, et 30430
8 exp genital diseases, female/ 130131
9 6 and 8 630
10 3 and 7 645 … , female/ci, ep, et 30430
8 exp genital diseases, female/ 130131
9 6 and 8 630
10 3 and 7 645
-
psnet.ahrq.gov/sites/default/files/2022-01/final_spotlight_stacked_opioid_administration_01.03.2022.pdf
January 01, 2022 - patient had a past medical history of morbid obesity,
hypertension, heart failure, chronic kidney disease … (stage 3),
diabetes, peripheral artery disease, and ischemic cardiomyopathy … – The code team focused on treating her ischemic heart disease and did not
administer naloxone. … sophisticated types of patient monitoring should be
considered, specifically for patients with coexisting disease
-
psnet.ahrq.gov/node/61082/psn-pdf
July 23, 2020 - spread of COVID-19 infection, the Centers for Medicare & Medicaid Services
(CMS) and the Centers for Disease … prevention
and control expertise, coupled with the unprecedented nature of a novel, highly infectious disease … Coronavirus Disease 2019 (COVID-19): People with Certain Medical Conditions. … Centers for Disease
Control and Prevention. https://www.cdc.gov/covid/risk-
factors/?
-
www.ahrq.gov/hai/cauti-tools/archived-webinars/engaging-nurse-physician-patient-slides.html
August 01, 2018 - Slide 27
Segment the Engagement Plan
Early Adopters
Hospitalists
Infectious Disease
Nephrologist … Sociable
Good Communication Skills
Motivated – Internal Engine
Consider Hospitalists, Infectious Disease … of technical and adaptive components
Assist with physician barrier removal
Urologist, infectious disease … Retrieved from http://www.ipfcc.org
Centers for Disease Control and Prevention.
-
psnet.ahrq.gov/web-mm/medication-safety-events-related-diagnostic-imaging
January 26, 2022 - for oversedation in the setting of opioid administration include obesity; hepatic, renal, and lung disease … Physical Status Classification System 8 ASA Class 1 Healthy patients ASA Class 2 Mild to moderate systemic disease … not limiting activity ASA Class 3 Severe systemic disease that limits activity but is not incapacitating … ASA class 4 Severe systemic disease that is constant threat to life ASA Class 5 Moribund patients not
-
meps.ahrq.gov/data_files/publications/st533/stat533.shtml
January 01, 2021 - top 5 percent were treated include hyperlipidemia; mental disorders; chronic obstructive pulmonary disease … (COPD), asthma, and other respiratory conditions; heart disease; and diabetes mellitus. … and older, persons receiving Social Security disability payments, and persons with end-stage renal disease … disorders
15.6
36.5
COPD, asthma, and other respiratory conditions
11.7
29.6
Heart disease
-
meps.ahrq.gov/data_files/publications/st533/stat533.pdf
January 01, 2021 - top 5 percent were treated include hyperlipidemia; mental
disorders; chronic obstructive pulmonary disease … (COPD), asthma, and other
respiratory conditions; heart disease; and diabetes mellitus. … and older, persons receiving Social
Security disability payments, and persons with end-stage renal
disease … 37.9
Mental disorders 15.6 36.5
COPD, asthma, and other
respiratory conditions 11.7 29.6
Heart disease
-
www.ahrq.gov/sites/default/files/wysiwyg/data/3P-RD-Physician-Practice-Directory-PUF-Codebook.pdf
March 01, 2023 - Medical specialties include: Allergy/Immunology; Cardiovascular Disease (Cardiology);
Interventional … Cardiology; Dermatology; Gastroenterology; Neurology; Cardiac Electrophysiology; Pulmonary Disease; … Nephrology; Infectious Disease; Endocrinology; Rheumatology; Addiction Medicine; Hematology; Hematology … Reconstructive Surgery; Colorectal Surgery; Thoracic Surgery; Urology; Hand
Surgery; Peripheral Vascular Disease
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disabilities-quality-improvement-outcomes_research-protocol.pdf
August 03, 2011 - critical analysis of the
existing literature on quality improvement strategies and issues for the disease … developmental disabilities,
disabilities acquired through trauma, disabilities which are manifestations of disease … processes,
and disabilities that are iatrogenically acquired from treatments for disease conditions … concerning a
person’s functioning and disability… as a dynamic interaction between health conditions
(diseases … Published Online: August 3, 2011
9. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 214730
10. exp Disease
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs026548-hershberger-final-report-2022.pdf
January 01, 2022 - positive health behavior changes.1 Patient
health behavior is a critical aspect of effect chronic disease … equipped to facilitate
the patient engagement and activation that are crucial in effective chronic disease … engagement in ACO practices
and patient-reported outcomes among adults with co-occurring chronic disease … as a risk
factor in personalized health care: a systematic review of the literature on chronic
disease … Effectiveness of motivational
interviewing interventions on medication adherence in adults with chronic diseases
-
hcup-us.ahrq.gov/reports/statbriefs/sb179-Emergency-Department-Trends.pdf
November 01, 2013 - Population-based disease management under fee-for-service Medicare. … Anemia (96)
Ovarian cyst (91)
Phlebitis, thrombophlebitis and thromboembolism (90)
Pulmonary heart disease … (59)
Malaise and fatigue (161)
Essential hypertension (238)
Biliary tract disease (219)
Sickle cell … Diabetes mellitus visits increased 33 percent, pulmonary heart disease visits increased 29 percent, … ICD-9-CM is the International Classification of Diseases, Ninth Revision, Clinical Modification, which
-
hcup-us.ahrq.gov/reports/statbriefs/sb147.jsp
January 01, 2013 - Introduction
Influenza is a serious respiratory disease that affects people of all ages. … The Centers for Disease Control and Prevention estimate that between 1976 and 2007 influenza-related … ICD-9-CM is the International Classification of Diseases, Ninth Revision, Clinical Modification, which … The annual impact of seasonal influenza in the U.S.: Measuring disease burden and costs. Vaccine. … MMWR. 2010;59(33):1057-1062.
3 Centers for Disease Control and Prevention.
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-agitation-aggression_executive.pdf
March 01, 2016 - APA Work Group on Alzheimer’s Disease and other Dementias,
Rabins PV, Blacker D, et al. … Effectiveness of
atypical antipsychotic drugs in patients with Alzheimer’s disease. … Light treatment for
neuropsychiatric behaviors in Alzheimer’s disease. … Therapeutic touch and agitation
in individuals with Alzheimer’s disease. … A disease management program for families
of persons in Hong Kong with dementia.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/hbSopN6uA9u-4EQuKtRGDP
October 01, 2011 - effects of weight-loss
treatment on long-term health outcomes (for example, death and
cardiovascular disease … Health Outcomes
Included trials did not demonstrate an effect on mor-
tality, cardiovascular disease … Randomised trial of the effect of orlistat on body weight and cardiovascular
disease risk profile in … Effect of orlistat on cardiovascular disease risk in obese adults. … Anthropometric cutoff points for predicting chronic diseases in the
Mexican National Health Survey 2000
-
integrationacademy.ahrq.gov/sites/default/files/2020-06/Lexicon.pdf
January 01, 2020 - ,
headache, fatigue,
insomnia, other
Medical
conditions
Patients with
one or more
medical
diseases … or
conditions,
e.g., diabetes,
asthma,
cardiovascular
disease, lung
disease
Complex cases
Complex … blend of
symptoms, problems,
conditions, diseases
or personal situations,
social determinants of … or
conditions, e.g.,
diabetes, asthma,
cardiovascular
disease, lung
disease
Complex cases
Complex … blend of
symptoms,
problems,
conditions,
diseases, personal
situations, social
determinants of
-
hcup-us.ahrq.gov/reports/methods/2008_01.pdf
January 01, 2008 - (0.01)
0.40*
(0.02)
122: Pneumonia
(except that caused by
tuberculosis or sexually
transmitted disease … (0.04)
5.27
(0.39)
3.98
(0.07)
3.31**
(0.22)
101: Coronary
atherosclerosis and
other heart disease … **
(47)
7.37
(0.17)
7.21
(0.54)
0.03
(0.00)
0.05
(0.00)
127: Chronic
obstructive pulmonary
disease … 11)
641**
(32)
4.44
(0.04)
4.30
(0.33)
1.22
(0.04)
1.01*
(0.07)
109: Acute
cerebrovascular
disease … 5.47
(0.04)
5.50 4.24
(0.09)
4.15 $19,059
(449)
$18,874
88: Chronic
obstructive
pulmonary
disease
-
www.ahrq.gov/sites/default/files/2025-05/nielsen2-report.pdf
January 01, 2025 - highlighted urologist‐led
stewardship initiatives in prostate cancer, advanced imaging in urinary stone disease … imaging
and strategies to reduce harms and costs associated with advanced imaging for urinary stone
disease … Urinary stone disease exerts a significant burden on patients within the health system, affecting nearly … educating patients that, though tests may be
important in effective diagnosis and treatment of many diseases … and that it is most
important to look for metastatic disease rather than synchronous disease in late‐stage